Vanessa Correia has a degree BSc (5 years) in Biology by Universidade de Évora, Évora, Portugal and a PhD in Health Science and Technologies, speciality Microbiology, integrated in the Doctoral Programme of the Academic Medical Centre of Lisbon, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. She began his career in 2005 at the National Institute of Health Dr. Ricardo Jorge, Lisbon, Portugal and there remains to the present days, working with influenza, SARS-CoV-2 and other viruses at the Prof. Helena Rebelo de Andrade team. Partly, also integrates the research team of Host-pathogen Interactions and is a member of the research team of several ongoing research projects. Working in the area of Medical and Health Sciences with an emphasis on Infectious Diseases, has been dedicated to the field of antiviral resistance surveillance and research for almost 15 years, and more recently to new antiviral targets and antiviral activity testing of new potential compounds. Holds strong expertise in phenotypic and genotypic evaluation of antiviral susceptibility, viral infection assays, in vitro and molecular testing of viral replication kinetics, and cytotoxicity evaluation and in vitro testing of the antiviral activity of compounds. Also holds expertise in bioinformatics and computational biology. Her portfolio includes nine scientific papers published in international journals and many scientific communications presented at international and national meetings.